ReviewJournal of Cancer2023
Comparing the Diagnostic Performance of Contrast-Enhanced Mammography and Breast MRI: a Systematic Review and Meta-Analysis.
Open access · goldAbstract readReview
In one paragraph
Review in Journal of Cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.
0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
15.6field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
42 citing papers in PubMed, 68 citations in OpenAlex.
- Early, delayed, or combined contrast-enhanced mammography for detecting residual disease after neoadjuvant chemotherapy in breast cancer.European radiology · 2026Article
- Diagnostic Performance of ⁶⁸Ga-FAPI PET/CT, ¹⁸F-FDG PET/CT, and Breast MRI for Assessing Tumor Extent and Axillary Metastasis in Breast Cancer: A Histopathology-Referenced Retrospective Study.European journal of nuclear medicine and molecular imaging · 2026Article
- ROI-Based Quantitative Analysis in Contrast-Enhanced Mammography: A Feasibility Study for Reproducible Enhancement Assessment.Diagnostics (Basel, Switzerland) · 2026Article
- Fewer breast cancers during post-treatment surveillance among patients initially staged using contrast-based imaging.Breast cancer research and treatment · 2026Article
- Autologous fat transfer-related calcifications and enhancement on contrast-enhanced mammography mimicking malignancy.Radiology case reports · 2026Article
- How to optimise breast cancer staging with contrast-enhanced mammography: current evidence and clinical implications.Insights into imaging · 2026Review
- Sustainability of contrast-enhanced breast imaging: a review of current evidence.Insights into imaging · 2026Review
- Contrast-enhanced mammography in the preoperative assessment of primary operable breast cancer: Results from a prospective, two-centre study.European journal of radiology open · 2026Article
- Effectiveness of Contrast-Enhanced Spectral Mammography Following Contrast-Enhanced Computed Tomography in Breast Cancer Diagnosis.Diagnostics (Basel, Switzerland) · 2026Article
- Clinical Performance of Contrast-Enhanced Mammography Versus Breast MRI in Women at Increased Breast Cancer Risk.Cancers · 2026Article
- ESR Essentials: post-treatment breast cancer surveillance from mammography to a more personalised approach-practice recommendations by the European Society of Breast Imaging.European radiology · 2026Review
- Ground-Glass Enhancement on Contrast-Enhanced Mammography: A CT-Inspired Qualitative Descriptor for Breast Lesion Characterization.Journal of clinical medicine · 2026Article
- Contrast-Enhanced Mammography and Deep Learning-Derived Malignancy Scoring in Breast Cancer Molecular Subtype Assessment.Medicina (Kaunas, Lithuania) · 2026Article
- Contrast-Enhanced Mammography in Breast Cancer Follow-Up: Diagnostic Value in Suspected Recurrence.Journal of imaging · 2025Article
- Article
- Contrast-enhanced mammography-guided biopsy: principles, challenges, and opportunities.Insights into imaging · 2025Review
- Impact of synthetic data on training a deep learning model for lesion detection and classification in contrast-enhanced mammography.Journal of medical imaging (Bellingham, Wash.) · 2025Article
- Head‑to‑head comparison of contrast‑enhanced mammography and MRI in assessing the tumor response to neoadjuvant therapy in breast cancer: a prospective, multireader study.La Radiologia medica · 2025Article
- Improving the diagnostic performance of contrast-enhanced mammography through lesion conspicuity and enhancement quantification.European radiology · 2025Article
- Detection of a contralateral breast malignancy using contrast-enhanced mammography (CEM) overlooked by initial MRI scan.Radiology case reports · 2025Article
Corrections and comments
- Commented on by
Authors and funding
9 authors at 3 institutions in 2 countries.
Lidewij M F H NeeterGROW School for Oncology and Reproduction, Maastricht University, Universiteitssingel 40, 6229 ER Maastricht, the Netherlands.
M M Quirien RobbeDepartment of Radiology and Nuclear Medicine, Maastricht University Medical Center+, P. Debyelaan 25, 6229 HX Maastricht, the Netherlands.
Thiemo J A van NijnattenGROW School for Oncology and Reproduction, Maastricht University, Universiteitssingel 40, 6229 ER Maastricht, the Netherlands.
Maxine S JochelsonDepartment of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
H P J RaatDepartment of Medical Imaging, Laurentius hospital, Mgr. Driessenstrtaat 6, 6040AX Roermond, the Netherlands.
Joachim E WildbergerDepartment of Radiology and Nuclear Medicine, Maastricht University Medical Center+, P. Debyelaan 25, 6229 HX Maastricht, the Netherlands.
Marjolein L SmidtDepartment of Surgery, Maastricht University Medical Center+, P. Debyelaan 25, 6229 HX Maastricht, the Netherlands.
Patty J NelemansDepartment of Epidemiology, Maastricht University, P. Debyelaan 1, 6229 HA Maastricht, the Netherlands.
Marc B I LobbesGROW School for Oncology and Reproduction, Maastricht University, Universiteitssingel 40, 6229 ER Maastricht, the Netherlands.
Maastricht University Medical Centre · NLLaurentius Ziekenhuis · NLMemorial Sloan Kettering Cancer Center · US
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4MNCI NIH HHS P30 CA008748
Abstract
PubMed holds no abstract for this paper.
Indexed as
breast MRIcontrast-enhanced mammographydiagnostic accuracy
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.